Vigeo Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Vigeo Therapeutics is a biotechnology company in clinical development pursuing new therapies for cancer. Based in Cambridge, Massachusetts, it operates within the biotechnology research sector and focuses on oncology approaches to treat cancer. The firm positions itself in the immuno-oncology space and is advancing candidates, such as VT1021, for single-agent use.

In May 2023, Vigeo Therapeutics announced data from a phase I/II expansion study of VT1021 evaluating its activity as a standalone therapy in recurrent glioblastoma. The update reflects progress in its clinical program targeting patients with difficult-to-treat tumors. The organization is small and located in Cambridge, serving oncology clinicians and patients seeking additional cancer treatment options.

Sign up for free to view info

Company overview Employee directory